Form 4: Plexus Director Sells Shares Under 10b5-1 Plan

Plexus Corp. Director Karen Marie Rapp sold 500 shares of common stock for $195.59 per share under a pre-arranged 10b5-1 plan.

Summary

• Karen Marie Rapp, a Director of Plexus Corp. (PLXS), disposed of 500 shares of common stock.
• The transaction occurred on February 27, 2026, at a price of $195.59 per share.
• The sale was executed pursuant to a Rule 10b5-1 plan, which was adopted on February 28, 2024.
• Following this transaction, Karen Marie Rapp beneficially owns 8,535 shares of Plexus Corp. common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, typical of a pre-scheduled insider transaction under a 10b5-1 plan, which does not inherently suggest positive or negative implications for the company's performance or stock price.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under a pre-arranged 10b5-1 plan, are common and generally do not signal a change in the company's fundamental outlook or performance. Such plans are often established to allow insiders to sell shares systematically over time while avoiding accusations of trading on material non-public information.

Stakeholder Impact

• Shareholders: A routine insider sale under a 10b5-1 plan is generally not expected to have a significant impact on shareholder sentiment or the company's stock price, as it is a pre-planned event rather than a reaction to new information.

Key Dates

Keywords

Plexus Corp, PLXS, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Director Transaction